Tandem Diabetes Care, Inc. Analysis
| Analyst Ratings |
|
Average Target Price
|
59.93
|
|
Average Rating
|
4.15
|
|
# Strong Buys
|
6
|
|
# Buys
|
3
|
|
# Holds
|
4
|
|
# Sells
|
0
|
|
# Strong Sells
|
0
|
| Quarterly Earnings History |
| Quarter |
EPS Estimate |
EPS Actual |
EPS Difference |
Surprise Percent |
|
2022-09-30
|
-0.05
|
-0.76
|
-0.71
|
-1420.00%
|
|
2022-06-30
|
0.02
|
-0.24
|
-0.26
|
-1300.00%
|
|
2022-03-31
|
-0.07
|
-0.23
|
-0.16
|
-228.57%
|
|
2021-12-31
|
0.21
|
0.16
|
-0.05
|
-23.81%
|
|
2021-09-30
|
0.06
|
0.09
|
0.03
|
50.00%
|
|
2021-06-30
|
-0.08
|
0.06
|
0.14
|
175.00%
|
|
2021-03-31
|
-0.16
|
-0.08
|
0.08
|
50.00%
|
|
2020-12-31
|
0.12
|
0.22
|
0.10
|
83.33%
|
| Annual Earnings History |
| Fiscal Year End |
EPS |
|
2022-12-31
|
-1.23
|
|
2021-12-31
|
0.23
|
|
2020-12-31
|
-0.63
|
|
2019-12-31
|
-0.44
|
|
2018-12-31
|
-3.59
|
|
2017-12-31
|
-16.81
|
|
2016-12-31
|
-25.75
|
|
2015-12-31
|
-11.98
|
|
2014-12-31
|
-19.53
|
|
2013-12-31
|
-27.10
|